| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/27/2002 | EP1181312A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
| 02/27/2002 | EP1181310A1 Chemokine receptor ccr3 antagonists |
| 02/27/2002 | EP1181305A1 Methods of modulating activity of prokaryotic ribosomes |
| 02/27/2002 | EP1181303A1 50 human secreted proteins |
| 02/27/2002 | EP1181300A1 6-o-carbamate ketolide derivatives |
| 02/27/2002 | EP1181299A1 C-2 modified erythromycin derivatives |
| 02/27/2002 | EP1181298A1 Novel 8a- and 9a-15-membered lactams |
| 02/27/2002 | EP1181291A2 Dna methyltransferase inhibitors |
| 02/27/2002 | EP1181288A1 Bicyclic oxazolidinones as antibacterial agent |
| 02/27/2002 | EP1181286A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 02/27/2002 | EP1181285A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 02/27/2002 | EP1181278A1 Cyclic amine derivatives and their uses |
| 02/27/2002 | EP1181276A1 Morpholino-n-ethyl ester derivative of an indole spla-2 inhibitor |
| 02/27/2002 | EP1181057A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 02/27/2002 | EP1181051A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF IMMUNOLOGICALLY-MEDIATED DISEASES USING i MYCOBACTERIUM VACCAE /i |
| 02/27/2002 | EP1181050A1 Methods for preventing reactivation of latent virus and controlling virus replication |
| 02/27/2002 | EP1181047A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 02/27/2002 | EP1181039A2 Therapeutic uses of bpi protein products in humans with otitis media with effusion |
| 02/27/2002 | EP1181038A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 02/27/2002 | EP1181025A2 Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
| 02/27/2002 | EP1181022A1 Medicinal compositions and their method of preparation |
| 02/27/2002 | EP1181010A1 Pharmaceutical chewing gum formulations |
| 02/27/2002 | EP1180999A2 Recombinant vaccine against botulinum neurotoxin |
| 02/27/2002 | EP1180937A1 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 02/27/2002 | EP1150990A4 Erythromycin a compounds and process for preparing the same |
| 02/27/2002 | EP0915841B1 Anilinopeptide derivatives |
| 02/27/2002 | EP0914127B1 Antifungal composition with enhanced bioavailability |
| 02/27/2002 | EP0865296B1 Influenza vaccine |
| 02/27/2002 | EP0827545B1 Retroviral vectors |
| 02/27/2002 | EP0784466B1 Use and composition of an anti-sexually transmitted diseases formulation |
| 02/27/2002 | CN1337968A Purification of echinocandin cyclopeptide compounds |
| 02/27/2002 | CN1337965A 3,6-disubstituted penam sulfone derivatives as antibacteriuls |
| 02/27/2002 | CN1337962A Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 02/27/2002 | CN1337959A 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 02/27/2002 | CN1337952A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 02/27/2002 | CN1337949A Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid as TACE inhibitor |
| 02/27/2002 | CN1337947A Acetylenic sulfonamide thiol TACE inhibitors |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1337944A Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid as TACE inhibitors |
| 02/27/2002 | CN1337941A Amide derivatives |
| 02/27/2002 | CN1337881A Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections |
| 02/27/2002 | CN1337880A HIV-1 mutation selecting from beta-2',3'-didehydro-2',3-dideoxy-5-fluorocytidine |
| 02/27/2002 | CN1337877A Method of preparing stable suspension of insoluble microparticles |
| 02/27/2002 | CN1337401A Thiophosphoryl amino acid ester compound and its prepn process |
| 02/27/2002 | CN1337261A Wudu ointment |
| 02/27/2002 | CN1337258A Beriberi treating Chinese medicine lotion |
| 02/27/2002 | CN1337245A Cold treating medicine |
| 02/27/2002 | CN1337244A Colera treating medicine |
| 02/27/2002 | CN1337232A Application of sodium deoxy taurocholate as synergist for antituber culosis antibiotic |
| 02/27/2002 | CN1337231A Application of sodium taurocholate as synergist for antituberculosis antibiotic |
| 02/27/2002 | CN1337229A Bifonazole-containing medicine composition |
| 02/27/2002 | CN1337228A Application of lipoic acid for improving biological utilization ratio of mineral salt |
| 02/27/2002 | CN1079832C Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
| 02/27/2002 | CN1079792C 酶抑制剂 Inhibitors |
| 02/27/2002 | CN1079673C Natural colour eyebrow streaking liquid and preparation method thereof |
| 02/27/2002 | CN1079660C Miniming trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound |
| 02/26/2002 | US6350873 Process for preparing 5′-acetylstavudine |
| 02/26/2002 | US6350869 Purification of antibiotic compound by salt formation of dicyclohexylamine |
| 02/26/2002 | US6350857 Fifty-four homologue (ffh) from streptococcus pneumoniae |
| 02/26/2002 | US6350856 Cytokine suppressive anti-inflammatory drug binding protein |
| 02/26/2002 | US6350854 Isolated 55 to 72 kDa protein which binds to prion proteins |
| 02/26/2002 | US6350784 Phytochemicals, surfactant, folic acid, |
| 02/26/2002 | US6350775 3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents |
| 02/26/2002 | US6350744 Pyrmidine or pyridine derivatives; antiarthritic and antiinflammatory agents; cachexia treatment; interleukin and tumor necrosis factor inhibitors |
| 02/26/2002 | US6350738 Gramnegative bactericides; fungicides, viricides; gonane derivatives with nitrogen-containing substituent(s) |
| 02/26/2002 | US6350736 phenyl methoxyalaninyl phosphate derivatives of 2',3'-didehydro-2',3'-dideoxythymidine with an electron-withdrawing moiety, such as p-bromo, for enhanced hydrolysis, have increased potency without high cytotoxic activity; inhibitors of HIV reverse transcriptase; thymidine-kinase (TK)-deficient cells |
| 02/26/2002 | US6350733 Aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 02/26/2002 | US6350600 A polypeptide encoding transfer rna-methyl transferase; screening antibiotics, therapy for streptococcus pneumoniae infections; drug development |
| 02/26/2002 | US6350598 MurD |
| 02/26/2002 | US6350472 Method of treating HIV infection with transdermal gel containing mammalian liver extract |
| 02/26/2002 | US6350468 Double capsule for the administration of active principles in multiple therapies |
| 02/26/2002 | US6350467 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 02/26/2002 | US6350457 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 02/26/2002 | US6350449 Immune composition comprising antibodies raised in mammal immunized with conjugate molecule comprising group b meningococcal polysaccharide having n-acetyl groups replaced with unsaturated acyl groups, covalently bound to protein |
| 02/26/2002 | CA2329474C Continuous low-dose cytokine infusion therapy |
| 02/26/2002 | CA2072484C Use of nadh or nadph against cancer and aids |
| 02/26/2002 | CA2052020C Pradimicin derivatives |
| 02/26/2002 | CA2046801C Substituted pyrroles |
| 02/26/2002 | CA2025728C Antimicrobial compositions |
| 02/26/2002 | CA2006717C Antibacterial anti-plaque oral composition mouthwash or liquid dentifrice |
| 02/21/2002 | WO2002014536A2 Odulating multiple lineage kinase proteins |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014489A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | WO2002014464A2 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 02/21/2002 | WO2002014448A2 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 02/21/2002 | WO2002014370A1 Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014362A2 A hepatitis c virus non-structural ns3/4a fusion gene |
| 02/21/2002 | WO2002014355A2 Novel mitogen activated kinase |
| 02/21/2002 | WO2002014349A2 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/21/2002 | WO2002014342A1 Steroid derived antibiotics |
| 02/21/2002 | WO2002014325A1 Crystals of penicillin and process for the production thereof |
| 02/21/2002 | WO2002014288A1 Use of triazinetrione sulfones for combating coccidiosis |
| 02/21/2002 | WO2002014281A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | WO2002014271A1 Proline derivatives and use thereof as drugs |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002014265A1 Novel 3-substituted urea derivatives and medicinal use thereof |
| 02/21/2002 | WO2002014261A2 4-substituted d-glutamic acid derivatives for use as antibiotic |
| 02/21/2002 | WO2002014251A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof |
| 02/21/2002 | WO2002014225A1 Ionization device which is mounted with gold pole or silver pole |